HealthCare News
Key Protein in Breast, Ovarian Cancer FoundThe protein, Rab25, could end up serving as both a predictor of prognosis for ovarian and breast cancer and a target for future treatments. "It could be both diagnostic and therapeutic. That's unusual," said Dr. Julia Smith, associate director of the cancer screening and prevention program at New York University Cancer Institute and director of the Lynne Cohen Breast Cancer Preventive Care Program, both in New York City. Smith was not involved in the study, which appears in the November issue of Nature Medicine. Even with current therapies, the compound could find a role to play. "If you don't have an aggressive cancer, you may not need more therapy," explained study author Dr. Gordon Mills, chairman of the department of molecular therapeutics at M.D. Anderson Cancer Center in Houston. "If you identify a cancer as aggressive, you might use different types of therapy. Even if you are not targeting this protein specifically, you may manage the patient differently." Read entire article... |
